Liquispx Liquid Saliva or Unrine Drug of Abuse Control

FDA 510(k) K012907 · Clinical Controls

Substantially Equivalent

510(k) numberK012907

Submission

Device name
Liquispx Liquid Saliva or Unrine Drug of Abuse Control
Applicant
Clinical Controls
Hawaiian Gardens, CA, US
Received
August 29, 2001
Decision date
September 28, 2001
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DIF – Drug Mixture Control Materials
Device class
Class I (low risk)
Regulation
21 CFR 862.3280
Specialty
Clinical Toxicology

Other 510(k)s with product code DIF

510(k)DeviceApplicantDecision
K153474Detectabuse Liquid Control Urine, Detectabuse Stat-Skreen Liquid Control Urine…DIF · Traditional Biochemical Diagnostics, Inc.02/23/2016SE
K132688Salivabuse Liquid Oral Fluid Control, Salivabuse Liquid Oral Fluid Control, Au/NzDIF · Traditional Biochemical Diagnostics, Inc.12/16/2013SE
K132174Multichem WBTDIF · Abbreviated Techno-Path Manufacturing , Ltd.09/20/2013SE
K121122Detectabuse Liquid Control, Detectabuse Stat-Skreen Liquid ControlDIF · Traditional Biochemical Diagnostic, Inc.07/03/2012SE
K121143Liquichek Whole Blood Immunosuppressant Control Tilevel (1,2 and 3)DIF · Traditional Bio-Rad Laboratories05/18/2012SE
K120504Liquichek Urine Toxicology Control, S10 & S10 Minipak, Liquichek Urine Toxicology…DIF · Traditional Bio-Rad Laboratories, Inc.03/27/2012SE
K103656Thermo Scientific Mas R Doa TotalDIF · Traditional Microgenics Corporation03/24/2011SE
K093577Liquichek Opiate ControlDIF · Traditional Bio-Rad Laboratories03/12/2010SE
K080085Mas Tox ControlDIF · Traditional Thermo Fisher Scientific04/30/2008SE
K080183Control Set Dat I, Contrl Set Dat II, Control Set Dat III, Control Set Amphetamine 1000…DIF · Abbreviated Roche Diagnostics Corp.03/25/2008SE

More from Roche Diagnostics Corp.

510(k)DeviceDecision
K964278Whole Blood Glucose Control Level 1,2,AND 3/WHOLE Blood Glucose Linearity…JJX · Traditional 11/22/1996SE
K962432Liquispex Urine (Micro)Albumin ControlJJX · Traditional 07/05/1996SE
K955691Serum Volatiles Control Level 1 & 2JJY · Traditional 04/24/1996SE
K955690Aqueous Ethanol/Ammonia Control Level 1, 2, & 3JJY · Traditional 04/24/1996SE
K946265Fibrinogen High Abnormal Control - Level 3GIL · Traditional 08/24/1995SE
K935598Plasma Fibrinogen Control Level 1/LEVEL 2GIL · Traditional 05/02/1995SE
K946266Ferritin Control - Level 1, 2, 3DGD · Traditional 02/10/1995SE
K946050Liquispex(Tm) Liquid CRP Control Level 1 and 2DCK · Traditional 02/10/1995SE
K946049Liquispex(Tm) Liquid B2M/CRP Control Level 1 and 2JJY · Traditional 02/10/1995SE
K946048Liquispex(Tm) Liquid B2M Control Level 1 and 2JZG · Traditional 02/10/1995SE

Questions and answers

When was Liquispx Liquid Saliva or Unrine Drug of Abuse Control cleared by the FDA?

Liquispx Liquid Saliva or Unrine Drug of Abuse Control (K012907) received a 510(k) decision of Substantially Equivalent on September 28, 2001, 30 days after the submission was received.

What is the product code of K012907?

The FDA product code is DIF – Drug Mixture Control Materials, a Class I (low risk) device regulated under 21 CFR 862.3280.